Evaluation of Right Ventricular Function and Metabolism Following Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension- Images of Rio
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2018
Price : $35 *
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 31 Jan 2017 Status changed from active, no longer recruiting to completed.
- 18 Jul 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016.